A

Abeona Therapeutics
D

ABEO

5.68000
USD
0.05
(0.89%)
Market Closed
Volume
0
EPS
-2
Div Yield
-
P/E
-3
Market Cap
246,915,450
OverviewSignalsIdeasNews
Related Instruments
    ALNY
    ALNY
    6.675
    (2.79%)
    245.505 USD
    B
    BLUE
    -0.69000
    (-7.52%)
    8.49000 USD
    C
    CRSP
    0.360
    (0.89%)
    40.720 USD
    E
    EDIT
    -0.01000
    (-0.75%)
    1.32000 USD
    N
    NTLA
    0.120
    (0.99%)
    12.190 USD
    Q
    QURE
    1.550
    (10.00%)
    17.050 USD
    REGN
    REGN
    -5.64
    (-0.80%)
    702.60 USD
    R
    RGNX
    0.22000
    (2.97%)
    7.63000 USD
    S
    SGMO
    0.17500
    (7.56%)
    2.49000 USD
    V
    VYGR
    0.06000
    (1.05%)
    5.76000 USD
    More
News

Title: Abeona Therapeutics

Sector: Healthcare
Industry: Biotechnology
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.